Jun 17 |
Olema Pharmaceuticals: Still Merits A Small Holding
|
Jun 14 |
TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors
|
Jun 4 |
Pfizer data for breast cancer therapy sends Olema higher
|
May 28 |
Olema Oncology to Participate in Upcoming Investor Conferences in June
|
May 24 |
Olema Pharmaceuticals (NASDAQ:OLMA) Is In A Good Position To Deliver On Growth Plans
|
May 15 |
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
|
May 9 |
Olema Pharmaceuticals GAAP EPS of -$0.56 beats by $0.02
|
May 8 |
Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
May 8 |
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
|
May 1 |
Olema Oncology to Participate in Upcoming Investor Conferences in May
|